Familial Adenomatous Polyposis (FAP)
Also known as: Familial Adenomatous Polyposis Coli / Adenomatous Polyposis Coli, Familial / FAP-Familial Adenomatous Polyposis / Familial Adenomatous Polyposis / Adenomatous Polyposis Coli / Familial multiple polyposis syndrome (disorder) / MYH-associated polyposis (disorder) / Polyposis coli / Familial polyposis / Adenomatous polyposis coli (morphologic abnormality)
Drug | Drug Name | Drug Description |
---|---|---|
DB00605 | Sulindac | An NSAID used to treat osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute subacromial bursitis or supraspinatus tendinitis, and acute gouty arthritis. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB13134 | Fluorine F-18 | 0 | Terminated | 1 |
DB15690 | Fluoroestradiol F-18 | 0 | Terminated | 1 |
DB14844 | Dordaviprone | 1 | Not Yet Recruiting | 1 |
DB05990 | Obeticholic acid | 1 | Not Yet Recruiting | 1 |
DB00482 | Celecoxib | 2 | Completed | 2 |
DB11672 | Curcumin | 2 | Completed | 1 |
DB11672 | Curcumin | 2 | Withdrawn | 1 |
DB06243 | Eflornithine | 2 | Completed | 1 |
DB00530 | Erlotinib | 2 | Completed | 1 |
DB14509 | Lithium carbonate | 2 | Enrolling by Invitation | 1 |
DB00331 | Metformin | 2 | Completed | 1 |
DB06803 | Niclosamide | 2 | Recruiting | 1 |
DB05990 | Obeticholic acid | 2 | Recruiting | 1 |
DB00877 | Sirolimus | 2 | Active Not Recruiting | 1 |
DB14276 | Turmeric | 2 | Completed | 1 |
DB00482 | Celecoxib | 2 / 3 | Completed | 1 |
DB00159 | Icosapent | 2 / 3 | Completed | 1 |
DB01586 | Ursodeoxycholic acid | 2 / 3 | Completed | 1 |
DB01586 | Ursodeoxycholic acid | 2 / 3 | Unknown Status | 1 |
DB06243 | Eflornithine | 3 | Completed | 1 |
DB06243 | Eflornithine | 3 | Withdrawn | 1 |
DB00159 | Icosapent | 3 | Recruiting | 1 |
DB00605 | Sulindac | 3 | Completed | 1 |
DB00605 | Sulindac | 3 | Withdrawn | 1 |
DB00207 | Azithromycin | 4 | Unknown Status | 1 |
DB00199 | Erythromycin | 4 | Unknown Status | 2 |
DB00482 | Celecoxib | Not Available | Terminated | 1 |
DB11672 | Curcumin | Not Available | Completed | 1 |